← Eichor
Study identifier: NCT05697328 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Barotrauma in Hyperbaric Oxygen Therapy

Condition: Barotrauma  ·  Sponsor: John Muir Health

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this research is to study whether the use of pseudoephedrine can help prevent middle ear trauma during HBOT. Pseudoephedrine is an approved drug that is used for temporary relief of nasal or sinus pain and pressure.

This description comes directly from the study's public registry record.

Talk to the study team

Jacinta Showers, RN  ·  9259473212  ·  jacinta.showers@johnmuirhealth.com

Todd Kessinger, MD, MD  ·  9259473212  ·  todd.kessinger_MD@johnmuirhealth.com

Always discuss trial participation with your own doctor first.

Locations (1)

John Muir HealthWalnut Creek, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05697328